Unichem Laboratories Complete Financial Statements
In FY2026, Unichem Laboratories (UNICHEMLAB) reported revenue ₹599 Cr, net profit ₹11 Cr and EPS ₹1.55, with a net profit margin of 1.8% and ROE of 0.4%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Review UNICHEMLAB P/E ratio to evaluate earnings-based valuation against sector peers.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
UNICHEMLAB Revenue, Net Profit & EBITDA — Year-on-Year Growth
UNICHEMLAB YoY (Mar 2025 vs Mar 2026) — revenue +0.5%, net profit -79.2%, EBITDA -36.6%, expenses +7.1%. For live price, earnings ratios and company overview, see Unichem Laboratories share price screener.
UNICHEMLAB Income Statement — Revenue, EBITDA & Net Profit
Unichem Laboratories revenue ₹599 Cr, EBITDA ₹59 Cr, net profit ₹11 Cr, EPS ₹1.55 (2026) — net profit margin 1.8%. Explore Unichem Laboratories intrinsic price to estimate fundamental worth using multiple valuation models.
| Particulars | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 | Sept 2018 | Mar 2018 | Jun 2018 | Dec 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 599 | 600 | 596 | 533 | 809 | 516 | 438 | 487 | 547 | 421 | 407 | 432 | 545 | 338 | 384 | 318 | 319 | 293 | 282 | 314 | 326 | 328 | 303 | 334 | 342 | 296 | 402 | 300 | 300 | 293 | 278 | 260 | 331 | 216 |
| Expenses | 540 | 571 | 504 | 504 | 476 | 452 | 532 | 443 | 448 | 407 | 419 | 395 | 435 | 352 | 302 | 311 | 345 | 284 | 255 | 300 | 313 | 288 | 277 | 305 | 296 | 295 | 350 | 294 | 292 | 318 | 260 | 276 | 325 | 192 |
| EBITDA | 59 | 29 | 93 | 29 | 332 | 64 | -94 | 44 | 99 | 14 | -12 | 37 | 110 | -14 | 83 | 7 | -26 | 9 | 27 | 14 | 13 | 40 | 26 | 29 | 46 | 1 | 52 | 6 | 8 | -25 | 18 | -16 | 5 | 24 |
| Operating Profit Margin % | 6.00% | 1.00% | 14.00% | 4.00% | 9.00% | 11.00% | -23.00% | 8.00% | 16.00% | 2.00% | -4.00% | 7.00% | 7.00% | -7.00% | 19.00% | 0.00% | -14.00% | 2.00% | 7.00% | -1.00% | 0.00% | 9.00% | 5.00% | 4.00% | 9.00% | -10.00% | 7.00% | -7.00% | -6.00% | -22.00% | -10.00% | -14.00% | -7.00% | -3.00% |
| Depreciation | 31 | 32 | 30 | 32 | 31 | 32 | 27 | 32 | 31 | 30 | 30 | 29 | 32 | 28 | 23 | 25 | 31 | 22 | 22 | 22 | 23 | 21 | 23 | 21 | 21 | 21 | 19 | 18 | 20 | 16 | 14 | 14 | 18 | 11 |
| Interest | 9 | 8 | 6 | 7 | 7 | 5 | 5 | 4 | 7 | 7 | 6 | 6 | 6 | 5 | 2 | 3 | 4 | 2 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 4 | 1 | 2 | 1 | 3 | 1 | 1 | 0 |
| Profit Before Tax | 19 | -11 | 58 | -9 | 293 | 27 | -126 | 8 | 62 | -22 | -47 | 2 | 73 | -47 | 58 | -21 | -61 | -16 | 3 | -9 | -11 | 18 | 0 | 7 | 24 | -22 | 29 | -14 | -13 | -43 | 2 | -31 | -14 | 13 |
| Tax | 8 | 1 | 5 | 1 | 29 | 3 | 3 | 6 | 4 | 3 | -3 | 3 | 0 | 23 | -14 | 3 | 3 | -3 | 3 | 2 | 3 | 9 | 18 | 5 | 0 | 1 | -9 | -8 | 1 | -2 | 4 | -10 | -14 | -16 |
| Net Profit | 11 | -12 | 53 | -11 | 264 | 25 | -129 | 2 | 58 | -25 | -44 | -1 | 73 | -71 | 72 | -23 | -64 | -13 | 0 | -12 | -14 | 9 | -17 | 2 | 24 | -22 | 38 | -6 | -15 | -41 | -2 | -21 | 0 | 29 |
| Earnings Per Share (₹) | 1.55 | -1.69 | 7.52 | -1.49 | 37.54 | 3.50 | -18.37 | 0.29 | 8.22 | -3.48 | -6.28 | -0.09 | 10.39 | -10.04 | 10.15 | -3.32 | -9.08 | -1.82 | -0.06 | -1.63 | -2.01 | 1.24 | -2.44 | 0.35 | 3.35 | -3.15 | 4.51 | -0.88 | -2.07 | -5.83 | 0.00 | -2.91 | -0.04 | 3.19 |
UNICHEMLAB Balance Sheet — Assets, Liabilities & Shareholders' Equity
UNICHEMLAB total assets ₹3,737 Cr, total equity ₹2,717 Cr, total liabilities ₹ Cr (2026) — ROE 0.4%.
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Total Assets | 3,737 | 3,569 | 3,275 | 3,193 | 3,319 | 3,126 | 3,145 | 3,150 | 3,194 | 1,527 | 1,284 | 1,169 |
| Current Assets | 2,197 | 2,030 | 1,743 | 1,589 | 1,648 | 1,377 | 1,687 | 2,038 | 2,337 | 749 | 600 | 564 |
| Fixed Assets | 1,311 | 1,300 | 1,252 | 1,257 | 990 | 884 | 870 | 810 | 578 | 491 | 403 | 416 |
| Capital Work in Progress | 100 | 31 | 123 | 148 | 494 | 568 | 331 | 92 | 238 | 250 | 237 | 123 |
| Investments | 975 | 0 | 1 | 2 | 264 | 392 | 550 | 926 | 901 | 14 | 14 | 35 |
| Other Assets | 3 | 2,239 | 1,899 | 1,787 | 1,571 | 1,282 | 1,395 | 1,321 | 1,476 | 772 | 630 | 595 |
| LIABILITIES | ||||||||||||
| Total Liabilities | ||||||||||||
| Current Liabilities | 134 | 127 | 99 | 118 | 148 | 63 | 47 | 27 | 50 | 70 | 86 | 89 |
| Non-Current Liabilities | ||||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||||
| Total Equity | 2,717 | 2,451 | 2,438 | 2,435 | 2,618 | 2,557 | 2,531 | 2,620 | 2,680 | 1,064 | 954 | 868 |
| Share Capital | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 18 | 18 | 18 |
| Reserves & Surplus | 2,703 | 2,437 | 2,424 | 2,421 | 2,604 | 2,543 | 2,517 | 2,606 | 2,666 | 1,045 | 936 | 849 |
UNICHEMLAB Cash Flow Statement — Operating, Investing & Financing
Unichem Laboratories operating cash flow ₹-7 Cr, investing ₹-242 Cr, financing ₹184 Cr, net cash flow ₹-65 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -7 | 14 | -85 | -260 | 33 | 20 | -328 | -112 | 68 | 112 | 78 |
| Investing Activities | -242 | 63 | 241 | 100 | -66 | -36 | -286 | 1,648 | -128 | -85 | -52 |
| Financing Activities | 184 | -106 | -81 | 191 | -121 | -62 | -2 | -881 | 59 | -33 | -51 |
| Net Cash Flow | -65 | -29 | 75 | 32 | -154 | -78 | -616 | 655 | -1 | -7 | -25 |